An equity assessment tool to improve the effectiveness of malaria programs.

Get the Malaria Matchbox Tool.






Comments

Post a Comment

Popular posts from this blog

Malaria situation worldwide.

Image
  This year’s report highlights several notable successes and encouraging trends – even amid serious challenges. Since 2000, 2.3 billion malaria cases and 14 million malaria deaths have been averted worldwide. There has been continued movement towards global elimination goals, with 47 countries and one territory now officially certified as malaria free by the World Health Organization (WHO). In 2024, progress in low-burden settings was sustained, with 37 countries reporting fewer than 1000 cases. Core effective interventions, such as the use of piperonyl butoxide (PBO) and dual active ingredient insecticide-treated mosquito nets (ITNs), rapid diagnostic tests (RDTs), seasonal and perennial malaria chemoprevention (SMC and PMC) and the malaria vaccine, were also expanded. Despite these gains, malaria remains a serious global health challenge, with an estimated 282 million cases and 610 000 deaths worldwide in 2024 – a slight increase compared with 2023. The WHO African Region contin...
Read more

What is needed now?

Image
  Reversing the upward trend in malaria burden requires urgent and coordinated action. Countries must strengthen leadership, governance and accountability mechanisms, building on the Yaoundé Declaration and the forthcoming Big Push framework. The goal remains clear: with the tools and resources available, no one should die from malaria. Sustained financing is essential to maintain global progress against malaria. History shows that even modest funding cuts can trigger malaria resurgence and increased disease burden. From 2024 to 2025, global malaria financing faced serious setbacks. Total funding in 2024 reached only US$ 3.9 billion, less than half of what is required, and Official Development Assistance (ODA) fell by 21%, largely due to reductions in support from the United States of America. Reductions in ODA have disrupted health systems, weakening routine surveillance. This has led to the cancellation or postponement of most planned surveys and increased the risk of stock-outs...
Read more